541 related articles for article (PubMed ID: 7841779)
21. Autologous and allogeneic transplantation with peripheral blood CD34+ cells: a pediatric experience.
Watanabe T; Kawano Y; Watanabe A; Takaue Y
Haematologica; 1999 Feb; 84(2):167-76. PubMed ID: 10091416
[TBL] [Abstract][Full Text] [Related]
22. Clinical use of allogeneic hematopoietic stem cells from sources other than bone marrow.
Arcese W; Aversa F; Bandini G; De Vincentiis A; Falda M; Lanata L; Lemoli RM; Locatelli F; Majolino I; Zanon P; Tura S
Haematologica; 1998 Feb; 83(2):159-82. PubMed ID: 9549928
[TBL] [Abstract][Full Text] [Related]
23. Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution.
Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Leblanc P; Symann ML
Cancer Res; 1994 Jul; 54(14):3800-7. PubMed ID: 7913409
[TBL] [Abstract][Full Text] [Related]
24. [Manipulation of hematopoietic stem cell grafts and their use in clinical practice].
Sumerauer D; Matĕjcková S; Hrubá A; Eckschlager T
Cas Lek Cesk; 2002 Jul; 141(13):411-6. PubMed ID: 12238028
[TBL] [Abstract][Full Text] [Related]
25. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S
Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
[TBL] [Abstract][Full Text] [Related]
26. The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation.
Newman A; Clutterbuck RD; DeLord C; Powles RL; Catovsky D; Millar JL
J Investig Med; 1995 Jun; 43(3):269-74. PubMed ID: 7614073
[TBL] [Abstract][Full Text] [Related]
27. [CD34+ cells in the autotransplant of bone marrow and peripheral blood].
Silvestri F; Baccarani M
Recenti Prog Med; 1992 Feb; 83(2):89-92. PubMed ID: 1380174
[TBL] [Abstract][Full Text] [Related]
28. [Clinical significance of autologous transplantation with hematopoietic stem cells in leukemia and solid tumors].
Hinterberger W; Adler V; Bauer K; Haberhauer G; Habertheuer KH; Höniger S; Huber K; Kier P; Kittel E; Ruckser R
Wien Med Wochenschr; 1995; 145(2-3):34-40. PubMed ID: 7762250
[TBL] [Abstract][Full Text] [Related]
29. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
[TBL] [Abstract][Full Text] [Related]
30. [Cellular therapy for intensification in oncology and hematology: manipulation of peripheral blood stem-cell products].
Douay L
Bull Cancer; 2001 Sep; 88(9):826-32. PubMed ID: 11604353
[TBL] [Abstract][Full Text] [Related]
31. Blood and marrow transplantation activity in Europe 1996. European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Passweg J; Baldomero H; Hermans J
Bone Marrow Transplant; 1998 Aug; 22(3):227-40. PubMed ID: 9720735
[TBL] [Abstract][Full Text] [Related]
32. New approaches to treating malignances with stem cell transplantation.
Margolis J; Borrello I; Flinn IW
Semin Oncol; 2000 Oct; 27(5):524-30. PubMed ID: 11049020
[TBL] [Abstract][Full Text] [Related]
33. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
Weisdorf D; Miller J; Verfaillie C; Burns L; Wagner J; Blazar B; Davies S; Miller W; Hannan P; Steinbuch M; Ramsay N; McGlave P
Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784
[TBL] [Abstract][Full Text] [Related]
34. [Autologous bone marrow transplantation--a new approach in the treatment of neoplastic hematologic diseases. I. Scientific principles and methodology of the treatment].
Nemet D
Lijec Vjesn; 1989 Dec; 111(12):466-74. PubMed ID: 2699909
[TBL] [Abstract][Full Text] [Related]
35. Hematopoietic recovery of ex vivo perfusion culture expanded bone marrow and unexpanded peripheral blood progenitors after myeloablative chemotherapy.
Engelhardt M; Douville J; Behringer D; Jähne A; Smith A; Henschler R; Lange W
Bone Marrow Transplant; 2001 Feb; 27(3):249-59. PubMed ID: 11277172
[TBL] [Abstract][Full Text] [Related]
36. [Autografts of bone marrow and current role of cytokines in hematology].
Gorin NC
C R Seances Soc Biol Fil; 1993; 187(4):452-86. PubMed ID: 7912642
[TBL] [Abstract][Full Text] [Related]
37. [The role of autologous hematopoietic cell transplantation in adult acute myelogenous leukemia].
Rucińska M; Machaczka M; Piatkowska-Jakubas B; Skotnicki AB
Przegl Lek; 1999; 56 Suppl 1():44-51. PubMed ID: 10494182
[TBL] [Abstract][Full Text] [Related]
38. [Umbilical cord blood as a source of stem cells].
Bojanić I; Golubić Cepulić B
Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834
[TBL] [Abstract][Full Text] [Related]
39. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
[TBL] [Abstract][Full Text] [Related]
40. Autologous bone marrow/stem cell transplantation: initial experience at a north Indian referral centre.
Gupta S; Kumar L; Raju GM; Kochupillai V; Shukla DK
Natl Med J India; 2000; 13(2):61-6. PubMed ID: 10835851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]